Nanomix Corporation (OTC: NNMX, NNMXD) has announced the appointment of Vidur Sahney as Chief Operating Officer. With over 20 years of experience, Mr. Sahney will oversee operations, including manufacturing and assay development. Additionally, the company has relocated its headquarters to a larger 9,325 square foot facility in San Leandro, California, which is 50% larger and half the cost of the previous site. These changes aim to enhance operational efficiency and support Nanomix's growth in point-of-care diagnostics.
Nanomix Corporation (OTC-PINK: NNMXD) has entered a $3 million securities purchase agreement with GHS Investments, LLC. This marks a significant transition for Nanomix from development to commercial operations. GHS, known for investing in promising small-cap companies, is expected to be a valuable partner. The agreement allows Nanomix to sell up to $3 million of common stock to GHS over several months. Nanomix specializes in mobile, point-of-care diagnostics, aiming to enhance healthcare delivery with rapid diagnostic solutions.
Nanomix Corporation (OTC-PINK: NNMXD, NNMX) will participate in the 2022 Virtual Growth Conference hosted by Maxim Group LLC from March 28-30, 2022. CEO David Ludvigson will present a company overview during the event. A pre-recorded presentation will be accessible for 72 hours from March 28, 9:00 a.m. ET, and an archived replay will be available on Nanomix's investor relations website.